Efficacy of add-on therapy of aliskiren to an angiotensin II receptor blocker on renal outcomes in advanced-stage chronic kidney disease: a prospective, randomized, open-label study
暂无分享,去创建一个
A. Nakashima | T. Kawai | T. Masaki | K. Sasaki | S. Doi | Yukio Yokoyama | Y. Kyuden | Kotaro Soji | Asuka Aoki | K. Fujiwara